title: Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
authors.affiliation: Laboratory Department of Pediatrics, UCLA School of Medicine 90024.
authors.forename: P C
authors.initials: PC
authors.lastname: Grimm
authors.forename: N M
authors.initials: NM
authors.lastname: Sekiya
authors.forename: L S
authors.initials: LS
authors.lastname: Robertson
authors.forename: B J
authors.initials: BJ
authors.lastname: Robinson
authors.forename: R B
authors.initials: RB
authors.lastname: Ettenger
mesh_terms: D000293:Adolescent; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000917:Antibody Formation; D004921:Erythropoietin / Q000627:therapeutic use*; D006084:Graft Rejection; D006680:HLA Antigens / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D016030:Kidney Transplantation / Q000276:immunology*; D010530:Peritoneal Dialysis; D011994:Recombinant Proteins / Q000627:therapeutic use; D014184:Transplantation, Homologous
chemical_list: D000888:Antibodies, Anti-Idiotypic; D006680:HLA Antigens; D015395:Histocompatibility Antigens Class I; D011994:Recombinant Proteins; D004921:Erythropoietin